Artwork

Inhoud geleverd door Focused Ultrasound Foundation. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Focused Ultrasound Foundation of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Player FM - Podcast-app
Ga offline met de app Player FM !

Ep11: Advancing Cancer Immunotherapy with Focused Ultrasound: A Conversation with Dr. Jill O'Donnell-Tormey

27:04
 
Delen
 

Manage episode 433102977 series 3556445
Inhoud geleverd door Focused Ultrasound Foundation. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Focused Ultrasound Foundation of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

In this episode, Dr. Jill O'Donnell-Tormey, CEO and Director of Scientific Affairs at the Cancer Research Institute (CRI), discusses the fascinating history of cancer immunotherapy, recent breakthroughs, and the potential role of focused ultrasound in enhancing immunotherapy treatments.
The conversation explores current challenges and opportunities in cancer immunotherapy, including the need for personalized treatment approaches and the promising potential of combining immunotherapy with other modalities like focused ultrasound. Dr. O'Donnell-Tormey explains key concepts such as checkpoint inhibitors and CAR T-cell therapy, making complex ideas accessible to listeners.
Listeners will gain valuable insights into the collaborative efforts between CRI and the Focused Ultrasound Foundation, learning how this partnership is driving innovation in cancer treatment. Dr. O'Donnell-Tormey also reflects on her career achievements and the evolving landscape of cancer research.
This episode offers a unique opportunity to learn from a leading expert in the field, providing a deeper understanding of the latest advancements in cancer immunotherapy and the potential for innovative technologies like focused ultrasound to improve treatment outcomes for cancer patients.
For more information about CRI visit cancerresearch.org

SHOW TRANSCRIPT

----------------------------
QUESTIONS?
Email podcast@fusfoundation.org if you have a question or comment about the show, or if you would you like to connect about future guest appearances.

Email info@fusfoundation.org if you have questions about focused ultrasound or the Foundation.

FUSF SOCIAL MEDIA

FUSF WEBSITE
https://www.fusfoundation.org
SIGN UP FOR OUR FREE NEWSLETTER
https://www.fusfoundation.org/newsletter-signup/
READ THE LATEST NEWSLETTER
https://www.fusfoundation.org/the-foundation/news-media/newsletter/
DOWNLOAD "THE TUMOR" BY JOHN GRISHAM (FREE E-BOOK)
https://www.fusfoundation.org/read-the-tumor-by-john-grisham/

  continue reading

14 afleveringen

Artwork
iconDelen
 
Manage episode 433102977 series 3556445
Inhoud geleverd door Focused Ultrasound Foundation. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Focused Ultrasound Foundation of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

In this episode, Dr. Jill O'Donnell-Tormey, CEO and Director of Scientific Affairs at the Cancer Research Institute (CRI), discusses the fascinating history of cancer immunotherapy, recent breakthroughs, and the potential role of focused ultrasound in enhancing immunotherapy treatments.
The conversation explores current challenges and opportunities in cancer immunotherapy, including the need for personalized treatment approaches and the promising potential of combining immunotherapy with other modalities like focused ultrasound. Dr. O'Donnell-Tormey explains key concepts such as checkpoint inhibitors and CAR T-cell therapy, making complex ideas accessible to listeners.
Listeners will gain valuable insights into the collaborative efforts between CRI and the Focused Ultrasound Foundation, learning how this partnership is driving innovation in cancer treatment. Dr. O'Donnell-Tormey also reflects on her career achievements and the evolving landscape of cancer research.
This episode offers a unique opportunity to learn from a leading expert in the field, providing a deeper understanding of the latest advancements in cancer immunotherapy and the potential for innovative technologies like focused ultrasound to improve treatment outcomes for cancer patients.
For more information about CRI visit cancerresearch.org

SHOW TRANSCRIPT

----------------------------
QUESTIONS?
Email podcast@fusfoundation.org if you have a question or comment about the show, or if you would you like to connect about future guest appearances.

Email info@fusfoundation.org if you have questions about focused ultrasound or the Foundation.

FUSF SOCIAL MEDIA

FUSF WEBSITE
https://www.fusfoundation.org
SIGN UP FOR OUR FREE NEWSLETTER
https://www.fusfoundation.org/newsletter-signup/
READ THE LATEST NEWSLETTER
https://www.fusfoundation.org/the-foundation/news-media/newsletter/
DOWNLOAD "THE TUMOR" BY JOHN GRISHAM (FREE E-BOOK)
https://www.fusfoundation.org/read-the-tumor-by-john-grisham/

  continue reading

14 afleveringen

Alle afleveringen

×
 
Loading …

Welkom op Player FM!

Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.

 

Korte handleiding